Combined intravitreal anti-VEGF and photodynamic therapy versus photodynamic monotherapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis of comparative studies.
<h4>Purpose</h4>The aim of this study was to evaluate the efficacy and safety of photodynamic therapy (PDT) combined with intravitreal vascular endothelial growth factor (VEGF) inhibitors compared to those of PDT alone in the treatment of polypoidal choroidal vasculopathy (PCV).<h4>...
Saved in:
| Main Authors: | Wei Wang, Miao He, Xiulan Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0110667 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polypoidal Choroidal Vasculopathy Treatment: Photodynamic Therapy, Anti-VEGF Monotherapy or Combination. Review of Clinical Studies
by: E. K. Pedanova, et al.
Published: (2019-06-01) -
Impact of photodynamic therapy combined with Anti-VEGF vs. Anti-VEGF monotherapy on choriocapillaris vessel density in polypoidal choroidal vasculopathy
by: Po-Chin Kuo, et al.
Published: (2025-04-01) -
Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy
by: Tien Yin Wong, et al.
Published: (2021-07-01) -
Comparative efficacy of photodynamic therapy (PDT), ranibizumab, aflibercept monotherapy, and combination therapies for polypoidal choroidal vasculopathy: a network meta-analysis of randomized controlled trials
by: Miguel A. Quiroz-Reyes, et al.
Published: (2025-07-01) -
Brolucizumab Monotherapy in Idiopathic Polypoidal Choroidal Vasculopathy:A Case Report
by: Mohan S, et al.
Published: (2025-01-01)